//
Luca Bertamini
Habib El-Khoury
David J. Lee
Ciara Murphy
Grace Fleming
Maya I. Davis
Jacqueline Perry
Christian J. Cea-Curry
Audrey Pentz
Thulisile Hlubi
Natalie Smyth
D.J. Sakrikar
Mark C. Perkins
Stephen Harding
Derek Troske
Gad Getz
Timothy R. Rebbeck
Maureen Joffe
Catherine R. Marinac
Nelson Leung
Carl Wenlong Chen
Irene Ghobrial
Department of Medical Oncology, Dana-Farber Cancer Institute, Cambridge, MA
Faculty of Health Sciences, University of the Witwatersrand, Sydney Brenner Institute for Molecular Bioscience, Johannesburg, South Africa
Department of Medicine, Massachusetts General Hospital, Boston, MA
Broad Institute of MIT and Harvard, Cambridge, MA
Harvard T.H. Chan School of Public Health, Boston, MA
Harvard Medical School, Boston, MA
Sydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Division of Hematology, Mayo Clinic, Rochester, Rochester, MN
Department of Medicine, Harvard Medical School, Boston, MA
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN
The Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA
National Health Laboratory Service, National Cancer Registry, Johannesburg, South Africa
United States
South Africa
United Kingdom
N/A
Oncology (ONC)
Endocrine/metabolic Diseases (ME)
Monoclonal gammopathy
Hematological malignancies
Multiple Myeloma
Solid malignancies
Cystatin C
Monoclonal gammopathy of undetermined significance
Lanthanum carbonate
N/A
Multinational
NA
N/A
N/A
N/A